GWAS IDs “Morning People”

In a large genome-wide association study, researchers from 23andMe locate 15 DNA regions associated with people’s preferences for early morning starts.

Written byCatherine Offord
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

WIKIMEDIA, DAVID ECCLESA CBS poll in 2007 suggested that just over half of US citizens felt “at their best” in the hours before midday. But whether you’re more of a night owl or a morning lark, a recent analysis of nearly 90,000 genomes from the personal genomics company 23andMe suggests that your preferred schedule is at least partially determined by your DNA. The study was published earlier this week (February 2) in Nature Communications.

“We identify 15 significantly associated loci, including seven near established circadian genes,” the authors wrote in their paper.

Screening spit samples mailed in by more than 89,000 customers, the team at 23andMe conducted genome-wide, single-nucleotide polymorphism (SNP) analyses to match self-reported “morningness” with genetic variation.

Beyond finding specific loci associated with early risers, the researchers found evidence to link a preference for early mornings—which tended to be more commonly reported in women—to a reduced predisposition to insomnia and sleep apnea, though the team’s Mendelian randomization analysis did not reveal a causal relationship.

Of course, using self-reported preferences for mornings does not guarantee an accurate classification of participants’ “morningness,” Barbara Stranger of the University of Chicago, who was not involved in the study, told Wired. Some ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • After undergraduate research with spiders at the University of Oxford and graduate research with ants at Princeton University, Catherine left arthropods and academia to become a science journalist. She has worked in various guises at The Scientist since 2016. As Senior Editor, she wrote articles for the online and print publications, and edited the magazine’s Notebook, Careers, and Bio Business sections. She reports on subjects ranging from cellular and molecular biology to research misconduct and science policy. Find more of her work at her website.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies